| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Academic drug discovery centres: the economic and organisational sustainability of an emerging model
|
Schultz Kirkegaard, Henriette
|
|
2014
|
19 |
11 |
p. 1699-1710
12 p.
|
artikel
|
| 2 |
Back-up strategies in drug discovery: what, how and when?
|
Provins, Laurent
|
|
2014
|
19 |
11 |
p. 1808-1811
4 p.
|
artikel
|
| 3 |
Bipolar disorder: recent clinical trials and emerging therapies for depressive episodes and maintenance treatment
|
Garay, Ricardo P.
|
|
2014
|
19 |
11 |
p. 1792-1800
9 p.
|
artikel
|
| 4 |
Contents page 1
|
|
|
2014
|
19 |
11 |
p. i-
1 p.
|
artikel
|
| 5 |
Contents page 1 continued
|
|
|
2014
|
19 |
11 |
p. iii-
1 p.
|
artikel
|
| 6 |
Corrigendum to “d-Arginine as a neuroprotective amino acid: promising outcomes for neurological diseases” [Drug Discov. Today 19 (2014) 627–636]
|
Griselda Canteros, M.
|
|
2014
|
19 |
11 |
p. 1829-
1 p.
|
artikel
|
| 7 |
Corrigendum to “Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery” [Drug Discov. Today 19 (2014), 171–182
|
Kell, Douglas B
|
|
2014
|
19 |
11 |
p. 1828-
1 p.
|
artikel
|
| 8 |
Crowdfunding drug development: the state of play in oncology and rare diseases
|
Dragojlovic, Nick
|
|
2014
|
19 |
11 |
p. 1775-1780
6 p.
|
artikel
|
| 9 |
Drug development and discovery: challenges and opportunities
|
Moridani, Majid
|
|
2014
|
19 |
11 |
p. 1679-1681
3 p.
|
artikel
|
| 10 |
Epigenetic code and potential epigenetic-based therapies against chronic diseases in developmental origins
|
Gao, Qinqin
|
|
2014
|
19 |
11 |
p. 1744-1750
7 p.
|
artikel
|
| 11 |
Expanding the scope of drug repurposing in pediatrics: The Children's Pharmacy Collaborative™
|
Blatt, Julie
|
|
2014
|
19 |
11 |
p. 1696-1698
3 p.
|
artikel
|
| 12 |
How to design a potent, specific, and stable angiotensin-converting enzyme inhibitor
|
Regulska, Katarzyna
|
|
2014
|
19 |
11 |
p. 1731-1743
13 p.
|
artikel
|
| 13 |
In pursuit of the ideal antifungal agent for Candida infections: high-throughput screening of small molecules
|
Wong, Sarah S.W.
|
|
2014
|
19 |
11 |
p. 1721-1730
10 p.
|
artikel
|
| 14 |
Manzamine alkaloids: isolation, cytotoxicity, antimalarial activity and SAR studies
|
Ashok, Penta
|
|
2014
|
19 |
11 |
p. 1781-1791
11 p.
|
artikel
|
| 15 |
New perspectives and lessons learned in the identification of impurities in drug development
|
Sasaki, Ryan R.
|
|
2014
|
19 |
11 |
p. 1691-1695
5 p.
|
artikel
|
| 16 |
Pharmacological effects of vitamin D and its analogs: recent developments
|
Sintov, Amnon C.
|
|
2014
|
19 |
11 |
p. 1769-1774
6 p.
|
artikel
|
| 17 |
PubChem applications in drug discovery: a bibliometric analysis
|
Cheng, Tiejun
|
|
2014
|
19 |
11 |
p. 1751-1756
6 p.
|
artikel
|
| 18 |
REACH and in silico methods: an attractive opportunity for medicinal chemists
|
Nicolotti, Orazio
|
|
2014
|
19 |
11 |
p. 1757-1768
12 p.
|
artikel
|
| 19 |
Stabilization of protein–protein interactions by small molecules
|
Giordanetto, Fabrizio
|
|
2014
|
19 |
11 |
p. 1812-1821
10 p.
|
artikel
|
| 20 |
Structural and functional analyses of bovine and porcine intestinal heparins confirm they are different drugs
|
Santos, Gustavo R.C.
|
|
2014
|
19 |
11 |
p. 1801-1807
7 p.
|
artikel
|
| 21 |
Targeting TNF: a therapeutic strategy for Alzheimer's disease
|
Cheng, Xin
|
|
2014
|
19 |
11 |
p. 1822-1827
6 p.
|
artikel
|
| 22 |
The rise (and decline?) of biotechnology
|
Kinch, Michael S.
|
|
2014
|
19 |
11 |
p. 1686-1690
5 p.
|
artikel
|
| 23 |
Towards a sustainable system of drug development
|
Moors, Ellen H.M.
|
|
2014
|
19 |
11 |
p. 1711-1720
10 p.
|
artikel
|
| 24 |
Trends in pharmaceutical targeting of clinical indications: 1930–2013
|
Kinch, Michael S.
|
|
2014
|
19 |
11 |
p. 1682-1685
4 p.
|
artikel
|
Tijdschrift beschrijving